MedPath

Effect of Aerobic Interval Training on Cardiovascular Function in Type 2 Diabetes

Not Applicable
Completed
Conditions
Type 2 Diabetes
Interventions
Other: High intensity aerobic interval training
Other: Continuous moderate intensity exercise
Registration Number
NCT01883258
Lead Sponsor
University of Florida
Brief Summary

The study objectives are:

1. To compare cardiovascular function in type 2 diabetes patients vs. healthy controls.

2. To compare the effect of 8 weeks of aerobic interval training versus continuous moderate exercise on cardiovascular function in adults with type 2 diabetes.

3. To examine the mechanisms underlying the exercise-related changes in cardiovascular function.

The investigators hypothesize that compared to continuous moderate intensity exercise training, interval training will be more effective in improving cardiovascular function in adults with type 2 diabetes.

Detailed Description

Cardiovascular function will be measured at baseline in adults with type 2 diabetes and in age-matched healthy controls. Research volunteers with type 2 diabetes who meet the inclusion criteria will be randomized to the aerobic interval training group, continuous moderate exercise group or non-exercise control group. At the end of the 8-week randomized control exercise intervention, baseline measures will be repeated.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
116
Inclusion Criteria

Not provided

Read More
Exclusion Criteria
  • History of diabetic proliferative retinopathy, autonomic or peripheral neuropathy
  • History of any relevant cardiovascular diseases (myocardial infarction, angina pectoris, history of coronary artery bypass surgery or angioplasty, congestive heart failure, or arrhythmia)
  • Hypertension (≥160 mmHg systolic or ≥100 mmHg diastolic)
  • History of renal impairment
  • History of gout or hyperuricemia
  • History of hepatic disease or infection with hepatitis B, C
  • History of seizures, or other relevant on-going or recurrent illness
  • Recent (within 3 months) or recurrent hospitalizations
  • Use of tobacco products
  • >5 % weight change in the prior 6 months.
  • Current intake of medications that may affect study results
  • Premenopausal women taking oral contraceptives and postmenopausal women taking hormone replacement therapy.
  • Pregnancy (positive urine pregnancy test) or lactation
  • For the healthy control group, history of diabetes.
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
High intensity aerobic interval trainingHigh intensity aerobic interval trainingType 2 diabetes subjects will complete 8 weeks of high intensity aerobic interval exercise training.
Continuous moderate intensity exerciseContinuous moderate intensity exerciseType 2 diabetes subjects will complete 8 weeks of continuous moderate intensity exercise training.
Primary Outcome Measures
NameTimeMethod
Change in vascular endothelial functionAt baseline and after 8 weeks of exercise training

Brachial flow mediated dilation using ultrasonography

Secondary Outcome Measures
NameTimeMethod
Change in factors related with endothelial functionAt baseline and after 8 weeks of exercise training

Blood and cellular markers of adiponectin, oxidative stress and inflammation.

Change in arterial stiffnessAt baseline and after 8 weeks of exercise training

Arterial stiffness (pulse wave velocity) and wave reflection (augmentation index) will be measured using the SphygmoCor device.

Change in cardiac functionAt baseline and after 8 weeks of exercise training

Left ventricular systolic and diastolic function will be measured using echocardiography.

Change in maximal oxygen consumptionAt baseline and after 8 weeks of exercise training

Maximal oxygen consumption will be measured using online computer-assisted open-circuit spirometry during incremental treadmill exercise.

Trial Locations

Locations (1)

University of Florida

🇺🇸

Gainesville, Florida, United States

© Copyright 2025. All Rights Reserved by MedPath